SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-031326
Filing Date
2020-11-17
Accepted
2020-11-17 19:49:17
Documents
1
Period of Report
2020-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7217
  Complete submission text file 0000899243-20-031326.txt   8788
Mailing Address C/O ARCH VENTURE PARTNERS 999 THIRD AVENUE, SUITE 3400 SEATTLE WA 98104
Business Address C/O ARCH VENTURE PARTNERS 999 THIRD AVENUE, SUITE 3400 SEATTLE WA 98104 857-400-4222
Codiak BioSciences, Inc. (Issuer) CIK: 0001659352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CODIAK BIOSCIENCES, INC. 35 CAMBRIDGEPARK DRIVE, SUITE 500 CAMBRIDGE MA 02140
Business Address
Howze Yalonda (Reporting) CIK: 0001828153 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39615 | Film No.: 201322558